HIGHLIGHTS
SUMMARY
Likelihood of continued treatment following discharge (Hass et_al, 2021; McKenzie et_al, 2012; Sharma et_al, 2016). Many individuals with OUD have had prior aversive experiences in jails, such as being forced to undergo withdrawal if currently on MOUD or receiving inadequate medication dosing, leading to negative beliefs about use of MOUD (Fu et_al, 2013; Rich et_al, 2015). Administrative barriers also limit MOUD availability in jails, including those related to licensing and regulations on dispensing of medications; other barriers are concerns about diversion and limited space and clinical capacity (Friedmann et_al, 2012; Grella et_al, 2020). In . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.